CA Stock MarketDetailed Quotes

WLLW Willow Biosciences Inc

Watchlist
  • 0.075
  • 0.0000.00%
15min DelayMarket Closed Dec 13 16:00 ET
10.82MMarket Cap-1.50P/E (TTM)

Willow Biosciences Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
152.67%1.7M
660.00%1.03M
-81.39%51K
42.75%1.17M
-82.55%89K
1,275.51%674K
-48.47%135K
274K
517.29%821K
5,566.67%510K
Operating revenue
152.67%1.7M
660.00%1.03M
-81.39%51K
42.75%1.17M
-82.55%89K
1,275.51%674K
-48.47%135K
--274K
517.29%821K
5,566.67%510K
Cost of revenue
Gross profit
Operating expense
-6.25%2.73M
-34.66%2.47M
-51.43%2.51M
-23.79%14.65M
-47.82%2.82M
-30.41%2.91M
-20.64%3.78M
6.02%5.16M
-17.53%19.22M
-16.97%5.41M
Selling and administrative expenses
31.53%997K
-36.91%889K
-60.05%1.05M
-33.88%6.02M
-54.42%1.27M
-61.66%758K
-36.70%1.41M
22.82%2.62M
5.79%9.1M
0.76%2.78M
-General and administrative expense
31.53%997K
-36.91%889K
-60.05%1.05M
-33.88%6.02M
-54.42%1.27M
-61.66%758K
-36.70%1.41M
22.82%2.62M
16.89%9.1M
43.11%2.78M
Research and development costs
-11.08%1.42M
-36.27%1.23M
-46.99%1.11M
-9.01%6.8M
-44.96%1.18M
-8.48%1.6M
11.82%1.93M
12.58%2.09M
-35.08%7.47M
-27.02%2.14M
Depreciation amortization depletion
-43.73%314K
-20.50%353K
-22.12%352K
-30.80%1.83M
-22.75%377K
20.26%558K
-45.52%444K
-48.58%452K
-17.11%2.65M
-40.63%488K
-Depreciation and amortization
-43.73%314K
-20.50%353K
-22.12%352K
-30.80%1.83M
-22.75%377K
20.26%558K
-45.52%444K
-48.58%452K
-17.11%2.65M
-40.63%488K
Operating profit
54.09%-1.03M
60.36%-1.45M
49.75%-2.46M
26.76%-13.48M
44.21%-2.74M
45.88%-2.24M
19.02%-3.65M
-0.39%-4.89M
20.60%-18.4M
24.69%-4.9M
Net non-operating interest income (expenses)
-1,833.33%-52K
-172.31%-47K
-128.45%-33K
-54.38%125K
-116.15%-26K
-95.89%3K
85.71%65K
544.44%116K
-29.20%274K
373.53%161K
Non-operating interest income
----
----
----
-11.00%267K
-37.97%116K
-95.89%3K
85.71%65K
----
-27.54%300K
206.56%187K
Non-operating interest expense
--52K
--47K
----
446.15%142K
----
----
----
----
-3.70%26K
----
Total other finance cost
----
----
128.45%33K
----
----
----
----
-544.44%-116K
----
----
Other net income (expenses)
-120.00%-1K
-300.00%-4K
6,550.00%133K
-90.55%318K
721.05%312K
-96.03%5K
-100.08%-1K
-99.89%2K
-79.79%3.37M
-97.03%38K
Gain on sale of security
-120.00%-1K
-300.00%-4K
-200.00%-2K
-91.48%318K
1,100.00%312K
-96.69%5K
-100.06%-1K
-99.89%2K
-77.72%3.73M
-97.97%26K
Special income (charges)
--0
--0
--135K
--0
--0
--0
--0
--0
-235.45%-369K
--12K
-Less:Restructuring and mergern&acquisition
----
----
----
--0
----
----
----
----
--384K
--3K
-Gain on sale of property,plant,equipment
--0
--0
--135K
--0
--0
--0
--0
--0
117.05%15K
----
Income before tax
51.55%-1.08M
58.23%-1.5M
50.61%-2.36M
11.70%-13.03M
47.93%-2.45M
43.35%-2.23M
-13.74%-3.58M
-60.66%-4.77M
-140.41%-14.76M
9.51%-4.7M
Income tax
165K
850.00%190K
2K
-109.43%-5K
-600.00%-25K
0
20K
0
53K
5K
Earnings from equity interest net of tax
Net income
44.15%-1.25M
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
Net income continuous operations
44.15%-1.25M
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
Noncontrolling interests
Net income attributable to the company
44.15%-1.25M
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
44.15%-1.25M
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
Diluted earnings per share
50.00%-0.01
66.67%-0.01
50.00%-0.02
16.67%-0.1
75.00%-0.01
33.33%-0.02
0.00%-0.03
-100.00%-0.04
-140.00%-0.12
0.00%-0.04
Basic earnings per share
50.00%-0.01
66.67%-0.01
50.00%-0.02
16.67%-0.1
75.00%-0.01
33.33%-0.02
0.00%-0.03
-100.00%-0.04
-140.00%-0.12
0.00%-0.04
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 152.67%1.7M660.00%1.03M-81.39%51K42.75%1.17M-82.55%89K1,275.51%674K-48.47%135K274K517.29%821K5,566.67%510K
Operating revenue 152.67%1.7M660.00%1.03M-81.39%51K42.75%1.17M-82.55%89K1,275.51%674K-48.47%135K--274K517.29%821K5,566.67%510K
Cost of revenue
Gross profit
Operating expense -6.25%2.73M-34.66%2.47M-51.43%2.51M-23.79%14.65M-47.82%2.82M-30.41%2.91M-20.64%3.78M6.02%5.16M-17.53%19.22M-16.97%5.41M
Selling and administrative expenses 31.53%997K-36.91%889K-60.05%1.05M-33.88%6.02M-54.42%1.27M-61.66%758K-36.70%1.41M22.82%2.62M5.79%9.1M0.76%2.78M
-General and administrative expense 31.53%997K-36.91%889K-60.05%1.05M-33.88%6.02M-54.42%1.27M-61.66%758K-36.70%1.41M22.82%2.62M16.89%9.1M43.11%2.78M
Research and development costs -11.08%1.42M-36.27%1.23M-46.99%1.11M-9.01%6.8M-44.96%1.18M-8.48%1.6M11.82%1.93M12.58%2.09M-35.08%7.47M-27.02%2.14M
Depreciation amortization depletion -43.73%314K-20.50%353K-22.12%352K-30.80%1.83M-22.75%377K20.26%558K-45.52%444K-48.58%452K-17.11%2.65M-40.63%488K
-Depreciation and amortization -43.73%314K-20.50%353K-22.12%352K-30.80%1.83M-22.75%377K20.26%558K-45.52%444K-48.58%452K-17.11%2.65M-40.63%488K
Operating profit 54.09%-1.03M60.36%-1.45M49.75%-2.46M26.76%-13.48M44.21%-2.74M45.88%-2.24M19.02%-3.65M-0.39%-4.89M20.60%-18.4M24.69%-4.9M
Net non-operating interest income (expenses) -1,833.33%-52K-172.31%-47K-128.45%-33K-54.38%125K-116.15%-26K-95.89%3K85.71%65K544.44%116K-29.20%274K373.53%161K
Non-operating interest income -------------11.00%267K-37.97%116K-95.89%3K85.71%65K-----27.54%300K206.56%187K
Non-operating interest expense --52K--47K----446.15%142K-----------------3.70%26K----
Total other finance cost --------128.45%33K-----------------544.44%-116K--------
Other net income (expenses) -120.00%-1K-300.00%-4K6,550.00%133K-90.55%318K721.05%312K-96.03%5K-100.08%-1K-99.89%2K-79.79%3.37M-97.03%38K
Gain on sale of security -120.00%-1K-300.00%-4K-200.00%-2K-91.48%318K1,100.00%312K-96.69%5K-100.06%-1K-99.89%2K-77.72%3.73M-97.97%26K
Special income (charges) --0--0--135K--0--0--0--0--0-235.45%-369K--12K
-Less:Restructuring and mergern&acquisition --------------0------------------384K--3K
-Gain on sale of property,plant,equipment --0--0--135K--0--0--0--0--0117.05%15K----
Income before tax 51.55%-1.08M58.23%-1.5M50.61%-2.36M11.70%-13.03M47.93%-2.45M43.35%-2.23M-13.74%-3.58M-60.66%-4.77M-140.41%-14.76M9.51%-4.7M
Income tax 165K850.00%190K2K-109.43%-5K-600.00%-25K020K053K5K
Earnings from equity interest net of tax
Net income 44.15%-1.25M53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M
Net income continuous operations 44.15%-1.25M53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M
Noncontrolling interests
Net income attributable to the company 44.15%-1.25M53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 44.15%-1.25M53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M
Diluted earnings per share 50.00%-0.0166.67%-0.0150.00%-0.0216.67%-0.175.00%-0.0133.33%-0.020.00%-0.03-100.00%-0.04-140.00%-0.120.00%-0.04
Basic earnings per share 50.00%-0.0166.67%-0.0150.00%-0.0216.67%-0.175.00%-0.0133.33%-0.020.00%-0.03-100.00%-0.04-140.00%-0.120.00%-0.04
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.